Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2033 ARTÍCULOS , VIENDO DEL 1546 AL 1560

Plasmalogens inhibit neuroinflammation and promote cognitive function

Hossain MS, Mawatari S, Fujino T.

Brain Res Bull. 2023 Jan;192:56-61. doi: 10.1016/j.brainresbull.2022.11.005. Epub 2022 Nov 5.

Plasma Exchange in Alzheimer's Disease

Rohrer L, Yunce M, Montine TJ, Shan H.

Transfus Med Rev. 2023 Jan;37(1):10-15. doi: 10.1016/j.tmrv.2022.09.005. Epub 2022 Oct 3.

Dysfunction of norepinephrine and its metabolites in Alzheimer's dementia - A review with meta-analysis

Portela Moreira I, Henriques T, Vieira-Coelho MA, Guimarães J.

Ageing Res Rev. 2023 Jan;83:101784. doi: 10.1016/j.arr.2022.101784. Epub 2022 Nov 9.

AChE as a spark in the Alzheimer's blaze - Antagonizing effect of a cyclized variant

Behl T, Kaur I, Sehgal A, Singh S, Sharma N, Gupta S, Albratty M, Najmi A, Alhazmi HA, Bungau S.

Ageing Res Rev. 2023 Jan;83:101787. doi: 10.1016/j.arr.2022.101787. Epub 2022 Nov 8.

Focus on Alzheimer's Disease: The Role of Fibroblast Growth Factor 21 and Autophagy

Yang L, Nao J.

Neuroscience. 2023 Feb 10;511:13-28. doi: 10.1016/j.neuroscience.2022.11.003. Epub 2022 Nov 11.

Interlacing the relevance of caspase activation in the onset and progression of Alzheimer's disease

Dhage PA, Sharbidre AA, Magdum SM.

Brain Res Bull. 2023 Jan;192:83-92. doi: 10.1016/j.brainresbull.2022.11.008. Epub 2022 Nov 11.

Anatomical biology guides a search for nutrients for the aging brain

Lauriola V, Brickman AM, Sloan RP, Small SA.

Mol Aspects Med. 2023 Feb;89:101154. doi: 10.1016/j.mam.2022.101154. Epub 2022 Nov 10.

Role of calcium dysregulation in Alzheimer's disease and its therapeutic implications

Joshi M, Joshi S, Khambete M, Degani M.

Chem Biol Drug Des. 2023 Feb;101(2):453-468. doi: 10.1111/cbdd.14175. Epub 2022 Dec 7.

Updated Understanding of the Glial-Vascular Unit in Central Nervous System Disorders

Yao D, Zhang R, Xie M, Ding F, Wang M, Wang W.

Neurosci Bull. 2023 Mar;39(3):503-518. doi: 10.1007/s12264-022-00977-9. Epub 2022 Nov 14.

Pathophysiological mechanism and natural preventive and therapeutic strategies of Alzheimer's disease

Basli A, Bounaas J.

Nutr Health. 2023 Sep;29(3):403-413. doi: 10.1177/02601060221137104. Epub 2022 Nov 14.

All the Tau We Cannot See

Hyman B.

Annu Rev Med. 2023 Jan 27;74:503-514. doi: 10.1146/annurev-med-042921-023749. Epub 2022 Nov 15.

Ginsenoside Rg1 in neurological diseases: From bench to bedside

Yang SJ, Wang JJ, Cheng P, Chen LX, Hu JM, Zhu GQ.

Acta Pharmacol Sin. 2023 May;44(5):913-930. doi: 10.1038/s41401-022-01022-1. Epub 2022 Nov 15.

Friend turned foe: TREM2 agonist in battles against tau

Carling G, Luo W, Gan L.

J Exp Med. 2023 Jan 2;220(1):e20221850. doi: 10.1084/jem.20221850. Epub 2022 Nov 18.

An investigation into the potential action of polyphenols against human Islet Amyloid Polypeptide aggregation in type 2 diabetes

Mahboob A, Senevirathne DKL, Paul P, Nabi F, Khan RH, Chaari A.

Int J Biol Macromol. 2023 Jan 15;225:318-350. doi: 10.1016/j.ijbiomac.2022.11.038. Epub 2022 Nov 15.

Implicative role of epidermal growth factor receptor and its associated signaling partners in the pathogenesis of Alzheimer's disease

Jayaswamy PK, Vijaykrishnaraj M, Patil P, Alexander LM, Kellarai A, Shetty P.

Ageing Res Rev. 2023 Jan;83:101791. doi: 10.1016/j.arr.2022.101791. Epub 2022 Nov 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias